T-Minus 10 By cover art

T-Minus 10

By: Slice of Healthcare LLC
Listen for free

  • Summary

  • 10 minute takes on the future of education in healthcare. Hosted by Tim Fitzpatrick. Produced by Slice of Healthcare. Sponsored by IKONA Health.
    © 2021-2022 Slice of Healthcare LLC
    Show more Show less
Episodes
  • Episode 39: Building Communities To Improve Patient Access & Outcomes w/ Jess Ackerman, VP at Responsum Health

    Episode 39: Building Communities To Improve Patient Access & Outcomes w/ Jess Ackerman, VP at Responsum Health
    Jul 20 2023
    What you’ll get out of this episodeListen in as host Tim Fitzpatrick chats with Jess Ackerman, VP of Strategic Partnerships and Impact at Responsum Health, about her experiences across healthcare and technology, including her path from Speech Language Pathology to patient-facing roles at health tech startups. Today, Jess leads partnerships for Responsum Health, a mission-driven digital health tech company that has built empowered, informed communities of patients with chronic health conditions to drive better outcomes and to strategically align them with resources, clinical trials and best options for their health. Responsum Health knows how to build communities, and fast.In this episode you’ll discover:How Jess and her team have launched and grown communities in as little as 3 weeks alongside their sponsor partners.Patient communities the Responsum Health team has helped so far, including menopause, chronic kidney disease (CKD), long-COVID, glaucoma, COPD, and even rare diseases like pulmonary fibrosis and Sanfilippo syndrome.How Responsum reduces clinical burden and improves communication, because patients can go to their doctor with a baseline level of education. Because of this, providers can perform at the top of their license and spend more time on treatment information rather than the basics.How Responsum engages patients with resources and education to help prepare a baseline for those initial conversations with their care team, and how this leads to better outcomes like recruitment, adherence, engagement, and reduced hospitalizations.Why the greatest barrier and competition to Responsum’s mission is the status quo, and what it will take to help patients, providers, and communities thrive if we can change it.Final Frontier - 5 Questions in 50 SecondsTop Challenge: Adoption of digital health tools Top Opportunity: Meeting patients where they areTech Trend You’re Following: Using our voices as diagnostic toolsPower of vocal quality as a health tracker (e.g. Sonde Health)Top Media Recs: The Humans by Matt HaigMad Honey by Jodi PicoultAuthor Elizabeth StroutThe Scent Keeper by Erica BauermeisteHealthcare / Tech Leader(s) You’re Following: T-Minus 10 guests are at the top of my list! 🚀🎉 Quotables“ Our Medicare community is quick to jump on the mobile apps and platforms. Our parent's generation between ages 70 - 80 – My mom is on her phone constantly researching and doing this and that – so I think people are judging a little bit quickly that the older population is not going to adopt the technology. I think it’s a huge opportunity because everyone has a smartphone. “Recommended ResourcesResponsum HealthResponsum Chronic Kidney Disease CommunityListen to Jess on the Empowered Patient Podcast Responsum Health Announces Partnership with Society for Women’s Health Research to Develop Unique Knowledge Resource for Women Living with MenopauseJoin the Conversation Jess Ackerman on LinkedIn“ This is my mom TODAY...She is 2 years, 3 months since her Stage IV Lung Cancer diagnosis; an "incidental finding" with NO symptoms, non-smoker, EGFR+ mutation. She was on the golf course when she received the call with the dreaded "c-word" diagnosis. Her story is both unique and like so many others with a stage IV, no symptom dx. #lungcancerawarenessmonth There has been considerable progress in reducing the burden of #lungcancer through effective #earlydetection and #precisiononcology ... and we need more! More #patientvoice. More #patientadvocacy. More integrated solutions. More focus on #patientexperience. More #access to #clinicaltrials #decentralizedclinicaltrials. My mom is strong and vibrant, in a #clinicaltrial at Dana-Farber Cancer Institute ... but DFCI cannot do it alone- in need of an ongoing holistic, personalized, integrated approach through #medtech #digitalhealth solutions.... Let's keep the momentum... Jasper Health Circuit Clinical
    Show more Show less
    31 mins
  • #38: Using AI, Data, and Telepharmacy To Drive Medication Optimization with Jason Rose, CEO of AdhereHealth

    #38: Using AI, Data, and Telepharmacy To Drive Medication Optimization with Jason Rose, CEO of AdhereHealth
    Jul 6 2023
    Episode 38: Using AI, Data, and Telepharmacy To Drive Medication Optimization with Jason Rose, CEO of AdhereHealthWhat you’ll get out of this episodeJoin host Tim Fitzpatrick as he chats with Jason Rose, CEO of AdhereHealth. In this voyage we learn more about AdhereHealth’s mission to deliver data-driven technology that improves medication optimization and quality measures to achieve value-based outcomes. We also hear how Jason’s 30 years of experience in this space shaped the company’s rebrand and transformation since he took over its helm in 2018. Today, AdhereHealth is the market leader using telepharmacy to overcome social determinants of health (SDOH) and improve the patient experience.Disclaimer: In this video Jason incorrectly states Dr. John Halamka left Beth Israel and is now at Johns Hopkins but he is actually at Mayo Clinic.In this episode you’ll discover:How AdhereHealth delivers purpose-built, innovative technology solutions to improve the quality of care, medication adherence , and cost outcomes.Why AdhereHealth is still the only national telepharmacy solution operating at scale in the United States today, touching more than 30 million people through its technologies and at-risk engagement services.How their unique combination of analytics, clinical workflow software, and proactive telepharmacy outreach addresses an estimated half a trillion dollars of unnecessary annual medical costs attributed to medication adherence issues.Why AdhereHealth developed the first-of-its-kind PRM (patient relationship management) software to further their understanding of patients’ Social Determinants of Health (SDoH).How Jason and his team think about things like risk and data architecture for their PRM platform by leveraging claims data (mile wide), medical history (mile deep), and pharmacy records (updated daily).Final Frontier - 5 Questions in 50 SecondsTop Challenge: Leveraging a combination of technology and clinician enablement that actually accelerates outcomes (hint - not an EHR)Top Opportunity: Medication adherenceTech Trend You’re Following: Public-Private PartnershipsTop Media Recs: Breaking the Habit of Being Yourself: How to Lose Your Mind and Create a New One by Dispenza, Joe. Modern Healthcare, Fierce Healthcare, Rama on Healthcare, WSJRockefeller, George LukasHealthcare / Tech Leader(s) You’re Following:Elon MuskDr. John Halamka, CIO at Mayo ClinicDr. David Brailer, First US Health IT Czar, Bush AdministrationSarah London, CEO of Centene CorporationDan Mendelson, CEO of Morgan HealthDavid Cordani, CEO of CignaGail Boudreaux, CEO of ElevanceQuotables“The pandemic was a…wasted opportunity to tackle [medication adherence] in a really big way. Who were those most hurt in the pandemic? It was not about the genetic code, it was about the zip code. It was the same patients before we still see today who are not getting their drugs for the chronic conditions.”“We’re using the data of yesterday to inform our decisions today, and artificial intelligence to drive our actions tomorrow.”Recommended ResourcesMedication Adherence Is a “Force Multiplier” for Medicare Advantage Profitability, Enrollment, Star Ratings (AJMC, 2023)The Quintuple Aim for Health Care Improvement: A New Imperative to Advance Health Equity - PubMed (nih.gov)Cost of Prescription Drug-Related Morbidity and Mortality - PubMed (nih.gov)Charting a New Path to At-Home Medication Adherence With Digital Pharmacy Support (AJMC, 2022)Join the Conversation Are you a healthcare innovator? Tell us what topics and people you’d like us to cover in future episodes:Jason Rose on LinkedInAdhereHealth on LinkedInAdhereHealth on Twitter““It’s a long-standing belief that star ratings are Darwinism in healthcare. If you don’t get the four stars, you’ve lost a percentage of your premium and lost funding to put into the product, and now because you’ve lost that, you’ve also lost membership enrollment,” says Rose. “And because you’ve lost the ability to compete with your peers, it’s going to take two years to come back with a higher star rating.” Great article Patient Safety & Quality Healthcare and Matt Phillion!#healthcare #sdoh #pharmacy #quality #starratings#medicationadherence” @Jason Rose on LinkedInAbout Your HostTim Fitzpatrick is the CEO of IKONA Health, a company using neurobiology and immersive technology to improve how patients learn about their care and treatment options. Tim co-founded IKONA based on his own patient experiences while serving in the US Navy and now in the VA health system. He has served as Principal Investigator on multiple federal research grants, has co-authored papers on learning science, VR, and mental health in the age of COVID-19, and has partnered with top healthcare investors and institutions including the National Science Foundation, Department of Defense, National Artificial Intelligence Institute, StartUp Health, On Deck, FundRx, MATTER and NVIDIA.
    Show more Show less
    37 mins
  • #37: Bridging The Gap Between Physical and Mental Health in Chronic Care with Dr. Hillary Lin, Co-Founder and CEO of Curio

    #37: Bridging The Gap Between Physical and Mental Health in Chronic Care with Dr. Hillary Lin, Co-Founder and CEO of Curio
    Jun 21 2023
    What you’ll get out of this episodeListen in as host Tim Fitzpatrick chats with Hillary Lin about Hillary’s journey from launching Curio at the start of the pandemic to navigating their latest pivot into cancer care. Hillary’s training and clinical experience led her to founding a holistic wellness startup that evolved into psychedelic-assisted therapy to where it is now as a comprehensive care delivery and navigation company. While Curio’s vision has not wavered, the team’s resilience and continued focus on patients has guided the evolution and expansion of their care infrastructure platform. In this episode you’ll discover:What led Curio to provide supportive care to patients who have recently been diagnosed with complex chronic illnesses like cancer.How Hillary and her team have adapted their ketamine-assisted therapy treatments in this new model, and the outcomes they’ve seen from PHQ-9 and GAD-7 in as little as one month for patients using the assisted therapy.Why Hillary is hopeful that generative AI will revolutionize patient education in healthcare and make managing diagnosis easier to navigate.Why New York City is the place to build your health tech startup – Spoiler Alert: a community of familiar faces and fearless friends!Final Frontier - 5 Questions in 50 SecondsTop Challenge: The recent company pivot. When Curio changed the company vision, Hillary worked on rebuilding the relationship with partners and gaining new patients. Also, becoming in-network providers with insuranceTop Opportunity: Building AI native care delivery.Tech Trend You’re Following: VR/AR - New Apple VR headsets.Top Media Recs: Outlive by Peter AttiaHealthcare / Tech Leader(s) You’re Following: Peter Attia Eric Topol Andrew YingQuotables“In the beginning, I was so burnt out and frustrated with healthcare that I very much wanted to start a wellness company. What I mean by that, is we were coaching people to explore their emotions. From the basics of even labeling emotions and understanding mindfulness around your emotions to regulating them and to much more sophisticated ways of interacting using emotional language and expression. We even used to host improv classes to help people explore.” @HillaryLin #joinCurio on Ep37 @T-Minus10 w/ @trfitzpatrick. Recommended ResourcesWe're redefining comprehensive care.We Are Overmedicated. How Can We Use Psychedelics To Heal Not Just Individuals, But Entire Systems? DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public Join the ConversationHillary Lin on LinkedInHillary Lin on TwitterCurio on Medium“I am a physician and founder of a mental healthtech startup (Curio). So what are my thoughts on emotional chatbots? At the time of writing, I'm undecided because this realm is still developing as we speak. I think early versions of emotional support chatbots will not feel incredibly fulfilling or validating to most users. However, there is a world where people may be so socialized to AI entities that they will feel at home interacting with them. For now, I'm more interested in how AI can help us think and stay accountable to our own goals. More of a coach, perhaps, than a therapist. The New York Times published an article on Inflection AI's Pi companion, which seems to validate this feeling. "With a level of enthusiasm only a robot could muster before coffee, Pi pushed me to break down my to-do list to create a realistic plan. Like much of the bot’s advice, it was obvious and simple, the kind of thing you would read in a self-help article by a productivity guru. But it was tailored specifically to me — and it worked.I'm curious to hear from people who have tried interacting with the latest emotional chatbots - what did you think about your experience?” (LinkedIn)“ 🎉 Breaking News for Digital Health Companies 🌐💊 The DEA has decided to extend the current COVID-19 telemedicine flexibilities for the prescription of controlled medications while they continue to consider the 38,000 comments received on their proposed telemedicine rules. This decision reflects a recognition of the essential role that telemedicine plays in providing Americans with access to necessary medications, and it is a significant milestone for companies like Curio. Our services, which include care navigation, coaching, therapy, medication management, and ketamine-assisted therapy, will continue to be available for those struggling with mental health challenges. We await further details on the draft Temporary Rule and its implications for digital health. This extension will enable us to continue offering transformative ketamine treatments virtually to those who need it most, bridging the gap between patients and quality care. 🙌💡” (LinkedIn)About Your HostTim Fitzpatrick is the CEO of IKONA Health, a company using neurobiology and immersive technology to improve how ...
    Show more Show less
    32 mins
Business & Careers Physical Illness & Disease Hygiene & Healthy Living Politics & Government
Show more Show less

What listeners say about T-Minus 10

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available